IGFBP1 and metabolic disease: The aim of this study was to investigate whether serum IGFBP-1 in its non-phosphorylated and phosphorylated forms as well as MMP-8 would associate with serum markers of low-grade inflammation and the metabolic profile in pregnant women at high risk for metabolic disorders, i.e. in overweight and obese women.